Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2020-12-24 (5 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75012), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE CENTRALE PICPUS : revenue, balance sheet and financial ratios
PHARMACIE CENTRALE PICPUS is a French company
founded 5 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75012),
this company of category PME
shows in 2024 a net income positive of 184 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CENTRALE PICPUS (SIREN 892383605)
Indicator
2024
2023
2022
2021
Revenue
N/C
N/C
N/C
N/C
Net income
184 306 €
226 588 €
218 241 €
182 786 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE CENTRALE PICPUS generates positive net income of 184 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2024: 183 k€ -> 184 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
184 306 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 98%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 43%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
98.215%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
42.658%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE CENTRALE PICPUS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
2023
2024
Debt ratio
770.34
281.009
159.457
98.215
Financial autonomy
9.601
21.575
31.754
42.658
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
98.222024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average-15 pts over 3 years
In 2024, the debt ratio of PHARMACIE CENTRALE PICPUS (98.22) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
42.66%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+16 pts over 3 years
In 2024, the financial autonomy of PHARMACIE CENTRALE PICPUS (42.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 151.01. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
151.01
Liquidity indicators evolution PHARMACIE CENTRALE PICPUS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2022
2023
2024
Liquidity ratio
161.155
126.329
150.15
151.01
Interest coverage
None
None
None
None
Sector positioning
Liquidity ratio
151.012024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average+13 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE CENTRALE PICPUS (151.01) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE CENTRALE PICPUS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE CENTRALE PICPUS is estimated at
2 573 048 €
(range 1 791 829€ - 3 849 427€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1791k€2573k€3849k€
2 573 048 €Range: 1 791 829€ - 3 849 427€
NAF 5 année 2024
Valuation method used
Net Income Multiple
184 306 €
×
14.0x
=2 573 048 €
Range: 1 791 830€ - 3 849 427€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CENTRALE PICPUS with other companies in the same sector:
Frequently asked questions about PHARMACIE CENTRALE PICPUS
What is the revenue of PHARMACIE CENTRALE PICPUS ?
The revenue of PHARMACIE CENTRALE PICPUS is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE CENTRALE PICPUS profitable?
Yes, PHARMACIE CENTRALE PICPUS generated a net profit of 184 k€ in 2024.
Where is the headquarters of PHARMACIE CENTRALE PICPUS ?
The headquarters of PHARMACIE CENTRALE PICPUS is located in PARIS (75012), in the department Paris.
Where to find the tax return of PHARMACIE CENTRALE PICPUS ?
The tax return of PHARMACIE CENTRALE PICPUS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CENTRALE PICPUS operate?
PHARMACIE CENTRALE PICPUS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart